Oliver Picken

Oliver Picken advises financial sponsors on a range of cross-border and domestic transactions, including leveraged buyouts, co-investments, minority investments and carve-outs. He also counsels sponsor clients’ portfolio companies on bolt-on acquisitions, restructurings, management incentive plans and other commercial matters.

Mr. Picken’s representations include advising:

• Hg on:
  • the increased investment by Hg Saturn 3 Fund and Hg Saturn 4 Fund in IFS, alongside ADIA, CPPIB, EQT, TA Associates and other minority shareholders, valuing the business at €15 billion
  • the sale of a co-controlling stake in IRIS Software Group Ltd to Leonard Green & Partners at an enterprise value of US$4 billion (£3.15 billion)
  • the separation of IFS and WorkWave
  • its significant investment in IFS and WorkWave businesses at a US$10 billion valuation
  • its majority investment in GTreasury SS, LLC
  • its majority investment in TrustQuay
  • its investment in Revalize at a US$1.8 billion valuation in partnership with current investors, TA Associates and the management team
  • the acquisition of TickTrade Systems Inc by SmartTrade (a portfolio company of Hg)
• BlackRock on its acquisition of Preqin at an enterprise value of £2.55 billion
• FTV Capital in connection with its acquisition of FundApps Limited
• Willis Towers Watson on its formation of a greenfield joint venture with Bain Capital to relaunch its treaty reinsurance business
• Montagu Private Equity on the sale of OpenGI
• JAB Holdings on its acquisition of SYNLAB VPG Limited
• Aptean, Inc., an enterprise software company owned by TA Associates Management, LP, Vista Equity Partners Management, LLC and Charlesbank Capital Partners, LLC, on the acquisition of Principal Logistics Technologies Ltd
• Waterlogic, a portfolio company of Castik Capital, on the sale of Billi Australia, Billi New Zealand and Billi U.K. to a subsidiary of Strix Group Plc
• Unily, a portfolio company of Farview Equity Partners and Silversmith Capital Partners, on a significant investment from CVC Growth Funds